Autoantibodies to neuronal antigens in children with new-onset seizures classified according to the revised ILAE organization of seizures and epilepsies

Epilepsia

Volumn 54, Issue 12, 2013, Pages 2091-2100

  Suleiman, Jehan ^a   Wright, Sukhvir ^b   Gill, Deepak ^a   Brilot, Fabienne ^a   Waters, Patrick ^b   Peacock, Ken ^c   Procopis, Peter ^a   Nibber, Anjan ^b   Vincent, Angela ^b   Dale, Russell C ^a   Lang, Bethan ^b  

^a UNIVERSITY OF SYDNEY   (Australia)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Autoimmune; CASPR2; Epilepsy; Glutamic acid decarboxylase; ILAE; N methyl d aspartate receptors; Pediatrics; VGKC

Indexed keywords

4 AMINOBUTYRIC ACID B RECEPTOR; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; ANTICONVULSIVE AGENT; AUTOANTIBODY; AXONIN 1; CORTICOTROPIN; GLUTAMATE DECARBOXYLASE; IMMUNOGLOBULIN; INFLIXIMAB; METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEOPTERIN; PREDNISOLONE; STEROID; VOLTAGE GATED POTASSIUM CHANNEL;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ANTICONVULSANT THERAPY; ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN DISEASE; CEREBROSPINAL FLUID ANALYSIS; CHILD; CHILDHOOD DISEASE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CROHN DISEASE; ENCEPHALOMALACIA; EPILEPTIC STATE; FAMILY HISTORY; FEBRILE CONVULSION; FEMALE; FIRST DEGREE RELATIVE; FOCAL EPILEPSY; HORMONAL THERAPY; HUMAN; IMMUNOTHERAPY; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; LENNOX GASTAUT SYNDROME; LEUKEMIA RELAPSE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MELAS SYNDROME; MOTOR DYSFUNCTION; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PLEOCYTOSIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOIMMUNOASSAY; RASMUSSEN SYNDROME; SCHOOL CHILD; SEIZURE; TONIC CLONIC SEIZURE; WEST SYNDROME;

EID: 84890119390     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12405     Document Type: Article

References (44)

1. Barajas RF, Collins E, Cha S, Geschwind MD,. (2010) Adult-onset drug-refractory seizure disorder associated with anti-voltage-gated potassium-channel antibody. Epilepsia 51: 473-477.
2. Beghi E, Carpio A, Forsgren L, Hesdorffer DC, Malmgren K, Sander JW, Tomson T, Hauser WA,. (2010) Recommendation for a definition of acute symptomatic seizure. Epilepsia 51: 671-675.
3. Beleza P,. (2012) Acute symptomatic seizures: a clinically oriented review. Neurologist 18: 109-119.
4. Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, Moshe SL, Nordli D, Plouin P, Scheffer IE,. (2010) Revised terminology and concepts for organisation of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology. Epilepsia 51: 676-685.
5. Bien CG, Scheffer IE,. (2011) Autoantibodies and epilepsy. Epilepsia 52: 18-22.
6. Blume WT, Lüders HO, Mizrahi E, Tassinari C, van Emde Boas W, Engel J,. (2001) Glossary of descriptive terminology for ictal semiology: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 1212-1218.
7. Brenner T, Sills GJ, Hart Y, Howell S, Waters P, Brodie MJ, Vincent A, Lang B,. (2013) Prevalence of neurologic autoantibodies in cohorts of patients with new and established epilepsy. Epilepsia 54: 1028-1035.
8. Brigo F, Bongiovanni LG, Cerini R, Manganotti P, Storti M, Fiaschi A,. (2011) Infliximab-related seizures: a first case study. Epileptic Disord 13: 214-217.
9. Commission on Classification and Terminology of the International League Against Epilepsy. (1989) Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 30: 389-399.
10. Dale RC, Brilot F, Fagan E, Earl J,. (2009a) Cerebrospinal fluid neopterin in paediatric neurology: a marker of active central nervous system inflammation. Dev Med Child Neurol 51: 317-323.
11. Dale RC, Irani SR, Brilot F, Pillai S, Webster R, Gill D, Lang B, Vincent A,. (2009b) NMDA receptor antibodies in pediatric dyskinetic encephalitis lethargica. Ann Neurol 66: 704-709.
12. Dhamija R, Renaud DL, Pittock SJ, McKeon A, Lachance DH, Nickels KC, Wirrell EC, Kuntz NL, King MD, Lennon VA,. (2011) Neuronal voltage-gated potassium channel complex autoimmunity in children. Pediatr Neurol 44: 275-281.
13. Engel J, International League Against Epilepsy (ILAE) (2001) A proposed diagnostic scheme for people with epileptic seizures and with epilepsy: report of the ILAE Task Force on Classification and Terminology. Epilepsia 42: 796-803.
14. Engel J,. (2006) Report of the ILAE classification core group. Epilepsia 47: 1558-1568.
15. Finke C, Prüss H, Scheel M, Ostendorf F, Harms L, Borowski K, Wandinger KP, Ploner CJ,. (2012) Anti-NMDA receptor antibodies in a case of MELAS syndrome. J Neurol 259: 582-584.
16. Florance NR, Davis RL, Lam C, Szperka C, Zhou L, Ahmad S, Campen CJ, Moss H, Peter N, Gleichman AJ, Glaser CA, Lynch DR, Rosenfeld MR, Dalmau J,. (2009) Anti-N-methyl- d -aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 66: 11-18.
17. Haberlandt E, Bast T, Ebner A, Holthausen H, Kluger G, Kravljanac R, Kröll-Seger J, Kurlemann G, Makowski C, Rostasy K, Tuschen-Hofstätter E, Weber G, Vincent A, Bien CG,. (2011) Limbic encephalitis in children and adolescents. Arch Dis Child 96: 186-191.
18. Hacohen Y, Wright S, Waters P, Agrawal S, Carr L, Cross H, De Sousa C, Devile C, Fallon P, Gupta R, Hedderly T, Hughes E, Kerr T, Lascelles K, Lin JP, Philip S, Pohl K, Prabahkar P, Smith M, Williams R, Clarke A, Hemingway C, Wassmer E, Vincent A, Lim MJ,. (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. JNNP 84: 748-755.
19. Ilingworth MA, Hanrahan D, Anderson CE, O'Kane K, Anderson J, Casey M, de Sousa C, Cross JH, Wright S, Dale RC, Vincent A, Kurian MA,. (2011) Elevated VGKC-complex antibodies in a boy with fever-induced refractory epileptic encephalopathy in school-age children (FIRES). Dev Med Child Neurol 53: 1053-1057.
20. Irani SR, Buckley C, Vincent A, Cockerell OC, Rudge P, Johnson MR, Smith S,. (2008) Immunotherapy-responsive seizure-like episodes with potassium channel antibodies. Neurology 71: 1647-1648.
21. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A,. (2010a) Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia. Brain 133: 2734-2748.
22. Irani SR, Alexander S, Waters P, Kleopa KA, Pettingill P, Zuliani L, Peles E, Buckley C, Lang B, Vincent A,. (2010b) N-methyl- d -aspartate antibody encephalitis: temporal progression of clinical and paraclinical observations in a predominantly non-paraneoplastic disorder of both sexes. Brain 133: 1655-1667.
23. Irani S, Bien C, Lang B,. (2011a) Autoimmune epilepsies. Curr Opin Neurol 24: 146-153.
24. Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJ, Zagami A, Bleasel A, Somerville ER, Smith SM, Vincent A,. (2011b) Fachiobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Ann Neurol 69: 892-900.
25. Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J,. (2010) Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia 51: 1069-1077.
26. Lai M, Hughes EG, Peng X, Zhou L, Gleichman AJ, Shu H, Matà S, Kremens D, Vitaliani R, Geschwind MD, Bataller L, Kalb RG, Davis R, Graus F, Lynch DR, Balice-Gordon R, Dalmau J,. (2009) AMPA receptor antibodies in limbic encephalitis alter synaptic receptor location. Ann Neurol 65: 424-434.
27. Lai M, Huijbers MG, Lancaster E, Graus F, Bataller L, Balice-Gordon R, Cowell JK, Dalmau J,. (2010) Investigation of LGI1 as the antigen in limbic encephalitis previously attributed to potassium channels: a case series. Lancet Neurol 9: 776-785.
28. Majoie M, de Baets M, Renier W, Lang B, Vincent A,. (2006) Antibodies to voltage-gated potassium channels in epilepsy. Epilepsy Res 71: 135-141.
29. McKnight K, Jiang Y, Hart Y, Cavey A, Wroe S, Blank M, Shoenfeld Y, Vincent A, Palace J, Lang B,. (2005) Serum antibodies in epilepsy and seizure-associated disorders. Neurology 65: 1730-1736.
30. Nabbout R,. (2012) Autoimmune and inflammatory epilepsies. Epilepsia 53: 58-62.
31. Niehusmann P, Dalmau J, Rudlowski C, Vincent A, Elger CE, Rossi JE, Bien CG,. (2009) Diagnostic value of N-methyl- d -aspartate receptor antibodies in women with new-onset epilepsy. Arch Neurol 66: 458-464.
32. Palace J, Lang B,. (2000) Epilepsy: an autoimmune disease? JNNP 69: 711-714.
33. Panayiotopoulos CP,. (2011) The new ILAE report on terminology and concepts for organization of epileptic seizures: a clinician's critical view and contribution. Epilepsia 52: 2155-2160.
34. Panayiotopoulos CP,. (2012) The new ILAE report on terminology and concepts for the organization of epilepsies: critical review and contribution. Epilepsia 53: 399-404.
35. Patterson RW, Zandi MS, Armstrong R, Schott JM, Vincent A,. (2013) The clinical relevance of positive voltage gated potassium channel (VGKC)-complex antibodies: experience from a tertiary referral centre. JNNP. Jun 11 [Epub ahead of print].
36. Pellkofer HL, Kuempfel T, Jacobson L, Vincent A, Derfuss T,. (2010) Non-paraneoplastic limbic encephalitis associated with NMDAR and VGKC antibodies. JNNP 81: 1407-1408.
37. Peltola J, Kulmala P, Isojarvi J, Saiz A, Latvala K, Palmio J, Savola K, Knip M, Kernen T, Graus F,. (2000) Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology 55: 46-50.
38. Quek AML, Britton JW, McKeon A, So E, Lennon VA, Shin C, Klein CJ, Watson RE, Kotsenas AL, Lagerlund TD, Cascino GD, Worrell GA, Wirrell EC, Nickels KC, Aksamit AJ, Noe KH, Pittock SJ,. (2012) Autoimmune epilepsy: clinical characteristics and response to immunotherapy. Arch Neurol 69: 582-593.
39. Shinnar S,. (2010) The new ILAE classification. Epilepsia 51: 715-717.
40. Suleiman J, Brenner T, Gill D, Brilot F, Antony J, Vincent A, Lang B, Dale RC,. (2011a) VGKC antibodies in pediatric encephalitis presenting with status epilepticus. Neurology 76: 1252-1255.
41. Suleiman J, Brenner T, Gill D, Troedson C, Sinclair AJ, Brilot F, Vincent A, Lang B, Dale RC,. (2011b) Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies. Dev Med Child Neurol 53: 1058-1060.
42. Suleiman J, Brilot F, Lang B, Vincent A, Dale RC,. (2013) Autoimmune epilepsy in children: case series and proposed guidelines for identification. Epilepsia 54: 1036-1045.
43. van Campen JS, Jansen FE, Brouwer OF, Nicolai J, Braun KP,. (2013) Interobserver agreement of the old and the newly proposed ILAE epilepsy classification in children. Epilepsia 54: 726-732.
44. Vincent A, Bien CG, Irani SR, Waters P,. (2011) Autoantibodies associated with diseases of the CNS: new developments and future challenges. Lancet Neurol 10: 759-772.